In 2024, the forecasted mortality rate for pancreas malignant neoplasms among females in Japan begins at 21.1 thousand deaths. The mortality rate shows a year-on-year increase, reaching 23.31 thousand by 2028. This represents a 10.45% increase in the number of female deaths over the forecast period, translating to an average compound annual growth rate (CAGR) of approximately 2.51% from 2024 onwards.

Future trends to watch for:

Advancements in medical technologies and treatments may impact mortality rates.
Government healthcare policies and preventive measures could alter future trajectories.
Public health awareness and early detection campaigns might play a crucial role in reducing mortality.